Eye-tracking to help identify autism in young children in Kenya
Tests eye-tracking for predicting autism in young children, including those born to mothers with HIV.
Plain-language title generated from the registry record
Registry title: The Alama Project: Autism Outcomes and Neurobehavioral Markers in Young Children Born to Mothers With HIV in Kenya
Key facts
- Where
- Eldoret, KenyaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children aged 24 to 72 months who are already in the Tabiri study. Some were exposed to HIV before birth and some were not.
- Age
- 24 to 72 months
- Sex
- Boys and girls can both join.
Main reasons for not taking part
- Children not enrolled in the Tabiri study (R01HD104552) cannot join.
- Caregivers must speak Kiswahili or English.
Read by machine on 9 November 2026.
Where in Kenya
- Moi Teaching and Referral HospitalEldoret, KenyaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Indiana University
- Trial code
- NCT06703125
- Record updated
- 26 May 2026
- Original description
The study will use a non-invasive remote eye-tracking system (Eyelink Portable Duo) to acquire a short series of eye-tracking measures to determine whether these can predict autism diagnoses in both children exposed to HIV and uninfected (CHEU) and children not exposed to HIV and uninfected (CHUU).Read full original descriptionShow less
The Alama Project: Autism Outcomes and Neurobehavioral Markers in Young Children Born to Mothers With HIV in Kenya
The study will use a non-invasive remote eye-tracking system (Eyelink Portable Duo) to acquire a short series of eye-tracking measures to determine whether these can predict autism diagnoses in both children exposed to HIV and uninfected (CHEU) and children not exposed to HIV and uninfected (CHUU).
Inclusion: Children enrolled in the Tabiri study (R01HD104552); CHEU or CHUU; Children ages 24-72 months; Caregivers of children must speak Kiswahili (local language) or English.
Exclusion: There will be no specific exclusion criteria. We anticipate that a small number of CHEU and CHUU will develop HIV prior to enrollment in the current study; these children will be included and will follow all general study procedures.